Vertex Pharmaceuticals (VRTX) Tax Rate (2011 - 2026)
Vertex Pharmaceuticals (VRTX) recorded quarterly Tax Rate of 17.68% in Q1 2026, up 68.2% quarter-over-quarter from 10.51% in Q4 2025, and up 616.0% on a YoY basis from 2.47% in Q1 2025.
Vertex Pharmaceuticals (VRTX) Tax Rate (2011 - 2026) Analysis & Trends
Vertex Pharmaceuticals' Tax Rate history runs 16 years deep, the most recent figure standing at 17.68% for Q1 2026.
- In Q1 2026, Tax Rate rose 616.0% year-over-year to 17.68%; the TTM figure through Mar 2026 stood at 16.02% (up 24543.0% YoY), while the FY2025 annual figure was 14.86%, down 30067.0% from the prior year.
- Tax Rate was 17.68% for Q1 2026 at Vertex Pharmaceuticals, up from 10.51% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 23.95% in Q4 2022 to a low of 5.97% in Q2 2024.
- Historically, Tax Rate has averaged 16.15% across 5 years, with a median of 17.68% in 2026.
- The sharpest annual moves came in 2022 and 2025: Tax Rate sank 23070 bps in 2022, then surged 2546 bps in 2025.
- A 5-year view of Tax Rate shows it stood at 23.95% in 2022, then slumped by 35 bps to 15.58% in 2023, then advanced by 26 bps to 19.67% in 2024, then sank by 47 bps to 10.51% in 2025, then jumped by 68 bps to 17.68% in 2026.
- The last three Tax Rate figures came in at 17.68% (Q1 2026), 10.51% (Q4 2025), and 16.62% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 12.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.68% |
| Mar 31, 2026 | 17.68% |
| Dec 31, 2025 | 10.51% |
| Dec 31, 2025 | 10.51% |
| Sep 30, 2025 | 16.62% |
| Sep 30, 2025 | 16.62% |
| Jun 30, 2025 | 19.49% |
| Jun 30, 2025 | 19.49% |
| Mar 31, 2025 | 11.51% |
| Mar 31, 2025 | 11.51% |
| Dec 31, 2024 | 19.67% |
| Dec 31, 2024 | 19.67% |
| Sep 30, 2024 | 14.60% |
| Sep 30, 2024 | 14.60% |
| Jun 30, 2024 | -5.97% |
| Jun 30, 2024 | -5.97% |
| Mar 31, 2024 | 14.03% |
| Mar 31, 2024 | 14.03% |
| Dec 31, 2023 | 15.58% |
| Dec 31, 2023 | 15.58% |